Skip to main content
Clinical Trials/NCT03340246
NCT03340246
Unknown
Not Applicable

Delayed or Immediate Local Treatment of Varicose Veins

Helsinki University Central Hospital1 site in 1 country140 target enrollmentMay 4, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Varicose Veins Leg
Sponsor
Helsinki University Central Hospital
Enrollment
140
Locations
1
Primary Endpoint
Need for sclerotherapy
Last Updated
3 years ago

Overview

Brief Summary

Varicose veins affect a majority of adult patients and cause a decreased quality of life. In recent years, standard practice has been to perform thermoablation and local phlebectomies in the same procedure. There is conflicting data on the long-term outcome of the local varicose veins; there seems to be a need for more re-interventions if the local varicosities are not treated immediately. On the other hand, the prolonged combined procedure increases procedural pain and bleeding, as well as the risk for complications from deep vein thrombosis/pulmonary embolism.

This trial aims to evaluate the need for immediate treatment of local varicosities and the potential sufficiency of main trunk treatment.

Registry
clinicaltrials.gov
Start Date
May 4, 2016
End Date
December 31, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Maarit Venermo

Professor of Vascular Surgery

Helsinki University Central Hospital

Eligibility Criteria

Inclusion Criteria

  • Ultrasound verified insufficiency of great saphenous vein (GSV)
  • GSV diameter 5-10 mm
  • C2-C4 varicosities
  • Most proximal insufficient branch in the distal thigh
  • Written and signed informed consent

Exclusion Criteria

  • Peripheral arterial disease
  • Body mass index \>40
  • Lymphoedema
  • Known allergy to sclerosant
  • Any known coagulopathy or history of deep vein thrombosis
  • Severe illness
  • Pregnancy

Outcomes

Primary Outcomes

Need for sclerotherapy

Time Frame: 3 months

Need for sclerotherapy of varicosities at three months after ablation of main trunk. Evaluated by the CEAP-classification of venous insufficiency. \>C2 will be eligible for treatment.

Secondary Outcomes

  • Occlusion rate of great saphenous vein(36 months)
  • Patient satisfaction(3 months)

Study Sites (1)

Loading locations...

Similar Trials